Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Tools and procedures for ex vivo vein arterialization, preconditioning and tissue engineering: a step forward to translation to combat the consequences of vascular graft remodeling.

Piola M, Soncini M, Prandi F, Polvani G, Beniamino Fiore G, Pesce M.

Recent Pat Cardiovasc Drug Discov. 2012 Dec;7(3):186-95. Review.

PMID:
22873197
2.

Tissue engineered small-diameter vascular grafts.

Schmedlen RH, Elbjeirami WM, Gobin AS, West JL.

Clin Plast Surg. 2003 Oct;30(4):507-17. Review.

PMID:
14621299
3.

Surgical technique for the implantation of tissue engineered vascular grafts and subsequent in vivo monitoring.

Koobatian MT, Koenigsknecht C, Row S, Andreadis S, Swartz D.

J Vis Exp. 2015 Apr 3;(98):e52354. doi: 10.3791/52354.

4.

Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9.

Chung AW, Rauniyar P, Luo H, Hsiang YN, van Breemen C, Okon EB.

J Vasc Surg. 2005 Oct;42(4):747-56.

5.

Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.

Berard X, Déglise S, Alonso F, Saucy F, Meda P, Bordenave L, Corpataux JM, Haefliger JA.

J Vasc Surg. 2013 May;57(5):1371-82. doi: 10.1016/j.jvs.2012.09.041. Epub 2013 Jan 23.

6.

Porcine small diameter arterial extracellular matrix supports endothelium formation and media remodeling forming a promising vascular engineered biograft.

Dahan N, Zarbiv G, Sarig U, Karram T, Hoffman A, Machluf M.

Tissue Eng Part A. 2012 Feb;18(3-4):411-22. doi: 10.1089/ten.TEA.2011.0173. Epub 2011 Dec 2.

PMID:
21919798
7.

Decellularized vein as a potential scaffold for vascular tissue engineering.

Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, Carabasi RA, Dimuzio PJ.

J Vasc Surg. 2004 Jul;40(1):146-53.

8.

Physiologically Modeled Pulse Dynamics to Improve Function in In Vitro-Endothelialized Small-Diameter Vascular Grafts.

Uzarski JS, Cores J, McFetridge PS.

Tissue Eng Part C Methods. 2015 Nov;21(11):1125-34. doi: 10.1089/ten.TEC.2015.0110. Epub 2015 Jun 24.

9.

Decellularized tissue-engineered blood vessel as an arterial conduit.

Quint C, Kondo Y, Manson RJ, Lawson JH, Dardik A, Niklason LE.

Proc Natl Acad Sci U S A. 2011 May 31;108(22):9214-9. doi: 10.1073/pnas.1019506108. Epub 2011 May 12.

10.

[Recellularization of tissue engineered vascular grafts in perfusion bioreactor].

Nasredinov AS, Anisimov SV, Vavilov VN, Puzanov MV, Kurapeev DI.

Tsitologiia. 2014;56(12):926-32. Russian.

PMID:
25929134
11.

Therapeutic strategies to combat neointimal hyperplasia in vascular grafts.

Collins MJ, Li X, Lv W, Yang C, Protack CD, Muto A, Jadlowiec CC, Shu C, Dardik A.

Expert Rev Cardiovasc Ther. 2012 May;10(5):635-47. doi: 10.1586/erc.12.33. Review.

12.

Engineering biological-based vascular grafts using a pulsatile bioreactor.

Huang AH, Niklason LE.

J Vis Exp. 2011 Jun 14;(52). pii: 2646. doi: 10.3791/2646.

13.

Artificial blood vessel: the Holy Grail of peripheral vascular surgery.

Kakisis JD, Liapis CD, Breuer C, Sumpio BE.

J Vasc Surg. 2005 Feb;41(2):349-54. Review.

14.

The fate of an endothelium layer after preconditioning.

Yazdani SK, Tillman BW, Berry JL, Soker S, Geary RL.

J Vasc Surg. 2010 Jan;51(1):174-83. doi: 10.1016/j.jvs.2009.08.074.

15.

Developments towards tissue-engineered, small-diameter arterial substitutes.

Bordenave L, Menu P, Baquey C.

Expert Rev Med Devices. 2008 May;5(3):337-47. doi: 10.1586/17434440.5.3.337. Review.

PMID:
18452384
16.

[Achievement and progress of dynamic culture conditions on the construction of engineered blood vessel substitutes].

Han Z, Kong H, Xu H.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008 Jun;25(3):716-9. Review. Chinese.

PMID:
18693463
17.

Readily available tissue-engineered vascular grafts.

Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE.

Sci Transl Med. 2011 Feb 2;3(68):68ra9. doi: 10.1126/scitranslmed.3001426.

18.

Evaluation of decellularized human umbilical vein (HUV) for vascular tissue engineering - comparison with endothelium-denuded HUV.

Mangold S, Schrammel S, Huber G, Niemeyer M, Schmid C, Stangassinger M, Hoenicka M.

J Tissue Eng Regen Med. 2015 Jan;9(1):13-23. doi: 10.1002/term.1603. Epub 2012 Oct 5.

PMID:
23038628
19.

The effect of thick fibers and large pores of electrospun poly(ε-caprolactone) vascular grafts on macrophage polarization and arterial regeneration.

Wang Z, Cui Y, Wang J, Yang X, Wu Y, Wang K, Gao X, Li D, Li Y, Zheng XL, Zhu Y, Kong D, Zhao Q.

Biomaterials. 2014 Jul;35(22):5700-10. doi: 10.1016/j.biomaterials.2014.03.078. Epub 2014 Apr 17.

PMID:
24746961
20.

Options for revascularization: artery versus vein: technical considerations.

Shuck J, Masden DL.

Hand Clin. 2015 Feb;31(1):85-92. doi: 10.1016/j.hcl.2014.09.008. Epub 2014 Nov 25. Review.

PMID:
25455359

Supplemental Content

Support Center